$8.68 0.00 (0%) Regulus Therapeutic Inc - NASDAQ

Jul. 27, 2015 | 04:00 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
7/21/2015RASTETTER WILLIAM HDirector61,235$10.19157.96%
7/17/2015ISIS PHARMACEUTICALS INCSubstantial Shareholder-111,000$10.21-2.10%
7/16/2015ISIS PHARMACEUTICALS INCSubstantial Shareholder-167,000$10.79-3.06%
7/15/2015ISIS PHARMACEUTICALS INCSubstantial Shareholder-65,133$10.76-1.18%
6/30/2015ISIS PHARMACEUTICALS INCSubstantial Shareholder-13,248$10.80-0.24%
4/21/2015XANTHOPOULOS KLEANTHIS GPresident and CEO60,000$0.381,619.43%
4/21/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-60,000$17.73-94.18%
4/20/2015XANTHOPOULOS KLEANTHIS GPresident and CEO66,071$0.381,783.29%
4/20/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-66,071$16.85-94.69%
4/17/2015XANTHOPOULOS KLEANTHIS GPresident and CEO73,929$0.381,995.38%
4/17/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-73,929$16.94-95.23%
4/13/2015CARTER BRUCE L ADirector-20,000$17.66-100.00%
3/05/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-65,614$20.07-71.56%
3/05/2015XANTHOPOULOS KLEANTHIS GPresident and CEO89,230$0.383,618.41%
3/05/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-23,616$20.81-90.55%
2/27/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-70$19.50-2.76%
2/27/2015XANTHOPOULOS KLEANTHIS GPresident and CEO70$0.382.84%
2/02/2015XANTHOPOULOS KLEANTHIS GPresident and CEO2,400$0.3897.32%
2/02/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-2,400$19.77-49.32%
1/30/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-3,300$19.50-57.23%
1/30/2015XANTHOPOULOS KLEANTHIS GPresident and CEO3,300$0.38133.82%
1/29/2015XANTHOPOULOS KLEANTHIS GPresident and CEO60,000$0.382,433.09%
1/29/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-33,773$17.77-54.07%
1/29/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-26,227$18.40-91.41%
1/28/2015Gibson Neil WChief Scientific Officer-71,345$17.98-89.18%
1/28/2015Gibson Neil WChief Scientific Officer-8,655$18.66-100.00%
1/28/2015XANTHOPOULOS KLEANTHIS GPresident and CEO85,000$0.383,446.88%
1/28/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-72,011$17.97-82.33%
1/28/2015XANTHOPOULOS KLEANTHIS GPresident and CEO-12,989$18.69-84.04%
11/28/2014Gibson Neil WChief Scientific Officer-1,500$19.63-1.84%
11/28/2014Gibson Neil WChief Scientific Officer2,500$1.743.13%
11/28/2014Gibson Neil WChief Scientific Officer-1,000$18.80-1.21%
11/12/2014ASTRAZENECA PLCSubstantial Shareholder-2,000,000$17.00-32.00%
11/03/2014ISIS PHARMACEUTICALS INCSubstantial Shareholder-1,279,411$15.94-18.83%
10/29/2014XANTHOPOULOS KLEANTHIS GPresident and CEO3,505$0.38142.13%
10/29/2014XANTHOPOULOS KLEANTHIS GPresident and CEO-100$20.41-3.90%
10/29/2014Gibson Neil WChief Scientific Officer2,500$1.743.13%
10/29/2014XANTHOPOULOS KLEANTHIS GPresident and CEO-1,400$18.66-23.45%
10/29/2014XANTHOPOULOS KLEANTHIS GPresident and CEO-2,005$19.78-43.86%
10/29/2014Gibson Neil WChief Scientific Officer-1,100$18.68-1.33%
10/29/2014Gibson Neil WChief Scientific Officer-1,200$19.67-1.47%
10/29/2014Gibson Neil WChief Scientific Officer-200$20.41-0.25%
10/24/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-1,850$15.19-0.03%
10/24/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-1,850$15.19-0.03%
10/24/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-350$15.50-0.01%
10/24/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-350$15.50-0.01%
10/24/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-1,054$14.63-0.02%
10/24/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-446$16.29-0.01%
10/24/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-446$16.29-0.01%
10/24/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-1,054$14.63-0.02%
10/23/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-1,700$14.24-0.03%
10/23/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-1,700$14.24-0.03%
10/23/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-450$14.90-0.01%
10/23/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-1,200$13.94-0.02%
10/23/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-450$14.90-0.01%
10/23/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-1,200$13.94-0.02%
10/22/2014Gibson Neil WChief Scientific Officer-3,300$14.44-3.96%
10/22/2014Gibson Neil WChief Scientific Officer3,300$1.744.13%
10/22/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-109,534$14.00-1.82%
10/22/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-109,534$14.00-1.59%
10/22/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-15,791$12.83-0.23%
10/22/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-9,283$12.18-0.13%
10/22/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-9,283$12.18-0.15%
10/22/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-15,791$12.83-0.26%
10/22/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-11,376$16.59-0.19%
10/22/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-11,376$16.59-0.17%
10/22/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-57,753$13.91-0.97%
10/22/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-15,156$14.67-0.22%
10/22/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-15,156$14.67-0.26%
10/22/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-57,753$13.91-0.84%
10/20/2014XANTHOPOULOS KLEANTHIS GPresident and CEO-300$7.00-10.85%
10/20/2014XANTHOPOULOS KLEANTHIS GPresident and CEO300$0.3812.17%
10/17/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-3,000$6.79-0.04%
10/17/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-3,000$6.79-0.05%
10/17/2014XANTHOPOULOS KLEANTHIS GPresident and CEO-400$7.04-13.96%
10/17/2014XANTHOPOULOS KLEANTHIS GPresident and CEO400$0.3816.22%
10/16/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-4,800$6.76-0.08%
10/16/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-4,800$6.76-0.07%
10/15/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-4,300$6.67-0.07%
10/15/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-4,300$6.67-0.06%
9/30/2014XANTHOPOULOS KLEANTHIS GPresident and CEO2,300$0.3893.27%
9/30/2014XANTHOPOULOS KLEANTHIS GPresident and CEO-2,300$7.02-48.26%
9/26/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-2,500$7.04-0.04%
9/26/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-2,500$7.04-0.04%
9/25/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-2,500$7.12-0.04%
9/25/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-2,500$7.12-0.04%
9/24/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-3,750$7.19-0.06%
9/24/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-3,750$7.19-0.05%
9/19/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-4,100$7.22-0.06%
9/19/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-4,100$7.22-0.07%
9/18/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-1,500$7.40-0.02%
9/18/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-1,500$7.40-0.02%
9/17/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-2,100$7.43-0.03%
9/17/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-2,100$7.43-0.03%
9/12/2014Gibson Neil WChief Scientific Officer2,200$1.742.75%
9/12/2014Gibson Neil WChief Scientific Officer-2,200$8.01-2.68%
9/12/2014ISIS PHARMACEUTICALS INCSenior Executive Officer-3,500$7.96-0.05%
9/12/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-3,500$7.96-0.06%
9/11/2014Gibson Neil WChief Scientific Officer2,000$1.742.50%
9/11/2014ALNYLAM PHARMACEUTICALS, INC.Substantial Shareholder-3,400$7.83-0.06%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (RGLS), click here.
  • Showing 1-100 of 203 items
  • 1
  • 2
  • 3
  • >>
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!